ArticleCancer immunology research2021

Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti-PD-1 Therapy Efficacy.

Anne Montfort et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.